Drug Database
Back to search

United States· US:13668-300_724c2e0f-2d55-4a25-a514-125371becd21

LEVETIRACETAM

A levetiracetam product containing levetiracetam, registered in United States by Torrent Pharmaceuticals Limited. The same ATC class is registered in 19 of our 19 countries.

ATC N03AX14US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLEVETIRACETAMATCN03AX14REGISTER NO.US:13668-300_724c2e0f…PACKS LISTED8CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levetiracetamAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levetiracetam is registered in 19 of 19 countries.

Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose
Search levetiracetam products by name

Levetiracetam · ATC N03AX14

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levetiracetam costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Levetiracetam · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$3.10
  • CH Switzerland$2.54
  • IT Italy$2.14
  • FR France$1.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LEVETIRACETAM
Manufacturer
Torrent Pharmaceuticals Limited
Country
United States (US)
ATC code
N03AX14
ATC class
Levetiracetam
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    1366830005
    500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-05)
  • ndc11
    1366830012
    120 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-12)
  • ndc11
    1366830025
    250 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-25)
  • ndc11
    1366830060
    60 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-300-60)
  • ndc11
    13668-300-05
  • ndc11
    13668-300-12
  • ndc11
    13668-300-25
  • ndc11
    13668-300-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for levetiracetam.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levetiracetam against other medicinesHow interaction checks work

Levetiracetam · interactions on record

258 records

  • 50 moderate
  • 3 minor
  • 164 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levetiracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levetiracetam products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Levebon, Levetiracetam +pharma
  • Belgium · Larofec, Levetiracetam A.Forall
  • Bulgaria · Levebon, Леветиракон Pharmacons
  • Cyprus · Levetiracetam Noridem, Lyberen
  • Czechia · Dretacen, Epiletam
  • Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
  • Denmark · Kevesy, Levetiracetam ”1a Farma”
  • Estonia · Levetiracetam Zentiva, Normeg
  • Spain · Laurak, Levetiracetam Almus
  • Finland · Larofec, Levetiracetam 1a Farma
  • France · Levetiracetam Accord, Levetiracetam Aguettant
  • United Kingdom (Northern Ireland) · Desitrend, Genlev
  • Greece · Ession, Kepricet
  • Croatia · Levetiracetam Kalceks, Lyvam
  • Hungary · Epiletam, Levetiracetam Kabi
  • Ireland · Larofec, Levetiracetam Brillpharma
  • Iceland · Keppra, Levetiracetam Accord
  • Italy · Epitiram, Grifoxina
  • Liechtenstein · Keppra, Levetiracetam Accord
  • Lithuania · Dretacen, Levetiracetam Kalceks
  • Luxembourg · Larofec, Levetiracetam Micro Labs
  • Latvia · Levetiracetam Kalceks
  • Malta · Levetiracetam Accord, Levetiracetam Aurobindo
  • Netherlands · Dretacen, Larofec
  • Norway · Keppra, Larofec
  • Poland · Cezarius, Lepsitam
  • Portugal · Cinaz, Laurak
  • Romania · Levetiracetam Accord, Levetiracetam Arena
  • Sweden · Levebon, Levetiracetam
  • Slovenia · Levetiracetam Kalceks
  • Slovakia · Epiletam, Levetiracetam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fdacd434-80c5-4ecf-a716-8cc117f7e3ff
GET /v1/drugs/fdacd434-80c5-4ecf-a716-8cc117f7e3ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "750",
  "substance": "LEVETIRACETAM",
  "productndc": "13668-300",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA091338",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about levetiracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console